Investigating Ozempic

Why did Novo Nordisk get banned from the British Pharmaceutical Society for two years - what kind of outrageous behaviour triggers a response like that? I look into the class action lawsuits in the USA and talk about previous lawsuits that Novo Nordisk have settled. I also look into the millions of dollars that Novo Nordisk have spent on health care professionals world wide. What are the implications of that?

Contact

investigating...

This week I take a comprehensive look at all of the Side Effects - or as the clinical trial data likes to call them - Adverse Events. I look at what is the percentage of people that suffer from them and find out that it is the Gastric Side Effects that affect the majority of the population who are using Ozempic or Wegovy for weight loss. I also talk to fascinating and vivacious Shauna about both of her experiences...

I look into why Wegovy possibly got approved at a 2.4mg dosage. What were the percentage of side effects found in clinical trials and why the hell did our Government Regulators say "yes". We take a look at the speed of weight loss and why it matters in Advertising. Plus what GLP1's have in common with the smash hit show "The Biggest Loser". I push for more personalised dosages of semaglutide and we look at the battle of Big Pharma ...

So much controversy is packed into this relatively short Investigating Ozempic Podcast.

How did the weekly administered Wegovy (semaglutide) drug get approved for the higher dosage of 2.4mg after doing a controversial dosage trial that conducted testing daily rather than weekly. Why did the Government Regulators approve this dosage after expressing some concerns and why did World Scientists publish questions over using higher dosag...

In 2017 two respected Danish Scientists claimed that higher dosages of the GLP1 Semaglutide, which had been planned as a treatment for Obesity, were not supported by the Clinical trials. I look at the timing of this article and their controversial statement. I search for the missing Phase II Ozempic Clinical trials and take a look at the Phase III Ozempic Trials on Diabetics and question the small amount of weight loss found alongs...

This week we look backwards in time in order to move forwards. We check out the first GLP1 drugs and take a longer look at Liraglutide which is a GLP1 found in Victoza (diabetes) and Saxenda (weightloss). We also chat to Lorrie and talk in depth about her journey on Saxenda and why she ended up choosing it over Ozempic.

Lorrie faced many challenges on her journey and I highlight three of the main ones that usually anyone faces when ...

This week I look at the previous and present CEO's of Novo Nordisk and examine their different passion projects and attitudes towards weight loss drugs. I ask the question why didn't the previous CEO push the button on the Wegovy clinical trials after many of the Ozempic clinical trials had been completed? What made him hesitate... and more importantly why did the new CEO make initiating those trials one of his first...

To see the fully formed picture of the new weight loss drugs I've had to dig deep. Years of research and interviews with scientists and health professionals. This is no junior jigsaw puzzle - it's a pretty tricky one - so get on board!

This week we follow the twists... and turn over three major puzzle pieces of the hidden picture to reveal the truth behind the new weight loss drugs. We look at Gover...

I want to tell you how this whole whole thing started. I was in the process of writing my fifth book, researching and writing about the new weight loss drugs - in particular Ozempic and Wegovy. I was reading clinical trials and medical reports. but the further I looked the more there was to see and what I found often wasn't pretty.

Plus I couldn't believe people were not even talking about these issues...like a...